🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cerus Corp director Shan Hua buys $4,974 in company stock

Published 14/05/2024, 23:38
CERS
-

In a recent transaction, Shan Hua, a director at Cerus Corp (NASDAQ:CERS), acquired additional shares in the company. The transaction, which took place on May 13, involved the purchase of 2,500 shares at a price of $1.9899 each, amounting to a total investment of $4,974.

This purchase reflects a continued confidence in the company's prospects by one of its directors. Following this acquisition, Hua's total holdings in Cerus Corp have increased to 32,386 shares of common stock. The transaction details were made public through a Form 4 filing with the Securities and Exchange Commission.

Cerus Corp, based in Concord, California, specializes in surgical and medical instruments and apparatus. The company's commitment to innovation and healthcare solutions is reflected in its product offerings and business strategy.

Investors often monitor insider transactions like these as they can provide insights into the sentiment of company executives and directors regarding the firm's future performance. While Shan Hua's recent purchase represents a vote of confidence, investors are always encouraged to consider the broader market context and individual investment goals when evaluating such information.

InvestingPro Insights

As Cerus Corp (NASDAQ:CERS) sees insider confidence with the recent purchase by director Shan Hua, the company's financial metrics and market performance offer additional insights. According to InvestingPro, Cerus Corp has experienced a significant return over the last week, with a 10.27% price total return. This short-term uptick complements a 16.57% return over the last month, indicating a positive momentum for the stock.

Despite the optimism from insider transactions, it is important to note that analysts do not expect Cerus to be profitable this year. The company's P/E ratio stands at -11.84, and when adjusted for the last twelve months as of Q1 2024, the P/E ratio slightly decreases to -12.64. This reflects challenges in turning revenue into net income. Moreover, Cerus is trading at a high Price / Book multiple of 7.49, suggesting that the stock may be priced optimistically relative to its book value.

InvestingPro Tips for Cerus Corp also highlight that while the company operates with a moderate level of debt, it has not been profitable over the last twelve months. Additionally, Cerus does not currently pay a dividend to shareholders, which may be a consideration for income-focused investors.

For those interested in a deeper dive into Cerus Corp's financials and market performance, InvestingPro offers a range of additional tips. Currently, there are seven more InvestingPro Tips available for Cerus Corp, which can be accessed for further analysis. As an incentive, readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.